4406
New Japan Chemical Co.,Ltd.
新日本理化
- Industry
- Chemicals
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2021
24,437
Mar 2022
32,358
Mar 2023
33,105
Mar 2024
32,863
Mar 2025
32,703
Operating profit(million JPY)
Mar 2021
287
Mar 2022
1,202
Mar 2023
-439
Mar 2024
361
Mar 2025
829
Operating profit margin(%)
Mar 2021
1.17
Mar 2022
3.71
Mar 2023
-1.33
Mar 2024
1.1
Mar 2025
2.53
Profit before tax(million JPY)
Mar 2021
680
Mar 2022
930
Mar 2023
-230
Mar 2024
520
Mar 2025
723
Profit(million JPY)
Mar 2021
501
Mar 2022
811
Mar 2023
-444
Mar 2024
220
Mar 2025
522
Total assets(million JPY)
Mar 2021
35,886
Mar 2022
40,086
Mar 2023
38,553
Mar 2024
40,114
Mar 2025
37,519
Cash and cash equivalents(million JPY)
Mar 2021
2,988
Mar 2022
3,329
Mar 2023
2,771
Mar 2024
3,695
Mar 2025
2,780
Cash flows from operating activities(million JPY)
Mar 2021
1,253
Mar 2022
1,078
Mar 2023
104
Mar 2024
3,578
Mar 2025
-224
Cash flows from investing activities(million JPY)
Mar 2021
-1,707
Mar 2022
-1,602
Mar 2023
-659
Mar 2024
-60
Mar 2025
-174
Cash flows from financing activities(million JPY)
Mar 2021
519
Mar 2022
861
Mar 2023
-3
Mar 2024
-2,596
Mar 2025
-513
Return on equity(%)
Mar 2021
3.5
Mar 2022
5.2
Mar 2023
-2.8
Mar 2024
1.3
Mar 2025
3
Equity ratio(%)
Mar 2021
42.4
Mar 2022
39.8
Mar 2023
41.2
Mar 2024
43.1
Mar 2025
47.4
Earnings per share(JPY per share)
Mar 2021
13.46
Mar 2022
21.76
Mar 2023
-11.92
Mar 2024
5.92
Mar 2025
14
Net assets per share(JPY per share)
Mar 2021
407.87
Mar 2022
427.44
Mar 2023
425.54
Mar 2024
463.6
Mar 2025
477.07
Dividend per share(JPY per share)
Mar 2021
3
Mar 2022
5
Mar 2023
-
Mar 2024
-
Mar 2025
4
Payout ratio(%)
Mar 2021
22.29
Mar 2022
22.98
Mar 2023
-
Mar 2024
-
Mar 2025
28.57
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.